Description of health condition studied Sexual dysfunction. Hypoactive sexual desire disorder
Conditions
Interventions
Intervention 1: Intervention group: Administration of Agnugol tablet containing 2.3-4.8 mg of vitex plant
Manufacture of Gol Dara Co.
at first, 4, 8 and 12 weeks. Intervention 2: Control group: Administration of placebo tablet containing starch 2.3-4.8 mg
Construction of Shahid Beheshti Pharmaceutical Faculty, Tehran, Iran
at first, 4, 8 and 12 weeks.
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
25 Years to 44 Years
Inclusion criteria
Inclusion criteria: All fertile women who referred for Pap smear and were healthy in gynecological and physical examinations and seeking treatment for the improvement and enhancement of sexual satisfaction
Exclusion criteria
Exclusion criteria: single, Pregnant and lactating, cannot read and write, Having a specific illness (thyroid problems, diabetes, psychiatric disorders, hyper-prolactonemia, liver problems, etc.) Stressful event in the last 6 months (death or disease of immediate family member, a major change in lifestyle) of any of the couples Mental problems (illness under the supervision or treatment of a physician) in each of the couples according to the woman's statement Treated for any sexual problems in each of the couples according to the woman's statement Alcohol or drug addiction in each of the couples according to the woman's statement Women whose husbands are unable to have normal sex (e.g., erectile dysfunction or premature ejaculation) Any illness in women, including abnormal bleeding, cervicitis and vaginitis without premenstrual tension and premenstrual syndrome. Taking vitamin supplements or hormonal pills like contraceptives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual Satisfaction. Timepoint: Before the intervention, 4, 8 and 12 weeks after the intervention. Method of measurement: Larson questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Medicinal effects. Timepoint: During and after medication. Method of measurement: Ask the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyedeh Fatemeh Dalil Heirati
Rasht University of Medical Sciences
Outcome results
None listed